ESRRB and breast cancer: Collectively, our data suggested that MLN4924 promotes ERRβ expression and thereby, augments the recruitment of p300 to the promoter of E-cadherin, culminating in the transcriptional upregulation of E-Cadherin expression to restrict breast cancer migration.